MarketsMarkets today
Dow Outruns Nasdaq As Rate-Sensitive Sectors Lead
The Dow gained 3.03% against 1.44% for the Nasdaq, with real estate up 3.96% and energy down 3.97%, as yields fell after the midterms.
The index tape was a rotation more than a rally. The Dow rose 3.03% to 53,356.12, the S&P 500 gained 1.58% to 7,688.62 and the Nasdaq added 1.44% to 25,736.51. The ordering of those three numbers is the story: the price-weighted, industrial-heavy Dow beat the technology-heavy Nasdaq by a margin of roughly two to one. WSJ reports AI stocks continued to weaken globally as investors digested the Democratic sweep of the midterms.
The sector table shows the same split. Real estate led at 3.96%, followed by consumer defensive at 1.14% and consumer cyclical at 1.12%. Technology managed only 0.21%. The pairing of real estate strength with falling Treasury yields is a standard one, since property valuations are discounted at long-end rates, and WSJ reports long-end yields hit eight-week lows. The data does not say which came first, so we do not claim causation.
Energy was the outlier, down 3.97%, the worst sector by a wide margin. The tape offers a candidate mechanism: oil prices stayed below $100 as traders weighed U.S.-Iran diplomacy, and Asia fuel oil benchmarks slumped as the market priced in a possible de-escalation. A producer group that had been carrying a war premium loses it when talks look likelier. Utilities fell 0.42%, the only other decliner.
The skeptical read is that breadth is better than the headline. Defensives and cyclicals both rose, which is not a risk-off tape, yet the largest growth names lagged. Scott Nations of Nations Indexes told CNBC the post-election rise was not overdone and breadth was encouraging, but warned that options markets may have shed risk too quickly. Cheap protection is not a forecast, but it is the kind of thing that costs more after a surprise.
For today, the pre-market inputs are Qualcomm's slump on weak phone chip sales, which pressures the chip complex Wednesday's tape already punished, and ConocoPhillips reporting third-quarter results before the open. Energy fell about 4% into that print. Dow futures were rising per WSJ, and that leaves the AI-versus-everything-else spread as the thing to track at 9:30.
More from the Markets desk
Europe Rises On Miners, Tech Lags
Reuters reports European shares rose on Thursday with mining stocks leading and technology lagging. That is the same divergence seen in New York: the cyclical, commodity-linked end of the index outperformed while the AI-exposed end drifted. Mining strength sits alongside the U.S. materials sector gain of 0.53%, though our data does not name the metal or the miners driving it.
The caution is that a one-line wire summary carries no index level, no percentage and no stock names, so the size of the move cannot be stated. What can be said is that the direction matches the AI selloff reported by WSJ as global in scope. When the same laggard group shows up in two time zones, it is more likely a positioning story than a company-specific one.
Next Beats Its Own Guidance
Next's quarterly sales beat its guidance, Reuters reports, on strong overseas performance. The retailer's guidance is the bar here, not analyst consensus, and clearing it suggests the company set it with room. The mechanism named is international: the growth came from outside the domestic market, where a UK retailer has historically had less share.
Our data gives no sales figure, no percentage and no updated full-year profit outlook, so the size of the beat is unknown. The useful read is the mix: a UK retailer growing abroad is less dependent on the British consumer, whose energy bills are a live issue in this week's Bank of England coverage.
Hikma Tightens Profit Outlook
Hikma tightened its annual profit outlook, Reuters reports, as branded medicines drove growth. Tightening a range is not raising it: the company narrowed the corridor, which signals confidence about where the year lands without a claim that it will land higher. The growth source named is branded drugs, the higher-margin end of a business better known for generics and injectables.
The wire summary supplies no revenue, profit figure or range, so we cannot say where within the prior guidance the new one sits. What is established is the driver. If branded medicines are carrying the year, mix is doing the work, and mix gains tend to persist longer than one-off price moves.
Nexi Beats, Keeps Its Guidance
Nexi posted third-quarter earnings above consensus and confirmed its guidance, according to Reuters. The two halves matter separately: a beat shows the quarter was better than the street modeled, while a confirmation without a raise says management is not prepared to extrapolate it. Payments companies often hold guidance after a beat when the fourth quarter carries seasonality they want to see first.
Our feed carries no revenue or earnings figures for Nexi. Alongside Italy's Fineco, which will update its strategy in February as growth momentum persists, and satellite firm SES topping estimates, the European financial and infrastructure earnings reported this morning lean positive, which fits the tape's tilt away from AI-linked names.
By the numbers
Also in this edition
Get tomorrow's edition by email. Free, one each morning.